Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV001268520 | SCV001447505 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004004936 | SCV004837676 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2023-11-02 | criteria provided, single submitter | clinical testing | This variant inserts 19 nucleotides in exon 50 of the RYR1 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, this variant has not been reported in individuals affected with RYR1-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of RYR1 function due to truncation variants is not an established disease mechanism for autosomal dominant malignant hyperthermia, although it is associated with other phenotype(s) (ClinVar variation ID: 987227). Due to insufficient evidence, this variant is classified as a Variant of Uncertain Significance for autosomal dominant malignant hyperthermia. |